External Funding Opportunities

We invite you to peruse the following list of funding opportunities that may be of interest to injury prevention researchers.  This information is abstracted for brevity; please refer to the sponsor’s website for complete information.

To add other opportunities to this list, please email us.

In addition, we often publicize funding opportunities via our mailing list.  Please become a member to join our mailing list and receive updated information.

• HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional) (Expiration Date: March 11, 2022)
• HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional) (Expiration Date: March 11, 2022)
• HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed) (Expiration Date: March 11, 2022)
• HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed) (Expiration Date: March 11, 2022)
• HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional) (Expiration Date: March 11, 2022)
• HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional) (Application Due Date: March 10, 2022)
• HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional) (Expiration Date: March 11, 2022)
• HEAL Initiative: HEAL Data2Action (HD2A) Data Infrastructure Support Center (U24 Clinical Trial Optional) (Expiration Date: March 11, 2022)
• HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional) (Application Due Date: March 10, 2022)
• HEAL Initiative: Pilot & Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional) (Application Due Date: March 10, 2022)
• HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) (Expiration Date: September 09, 2022)
• HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 – Clinical Trial Not Allowed) (Expiration Date: September 09, 2022)
• Understanding Polydrug Use Risk and Protective Factors, Patterns, and Trajectories to Prevent Drug Overdose (Closing Date for Applications: February 24, 2022)
• Harm Reduction Grant Program (Application Due Date: February 7, 2022)
• Rural Communities Opioid Response Program-Behavioral Health Care Technical Assistance (Closing Date for Applications: March 9, 2022)
• NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) (Expiration Date: March 03, 2022; Letter of Intent Due: February 02, 2022)
• Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic (Application Due Date: March 15, 2023)
• Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) (Application Due Dates: July 19, 2022; November 15, 2022; July 19, 2023; November 15, 2023 – each letter of intent due 30 days prior)
• Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) (Expiration Date: November 16, 2023)
• Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) (Closing Date for Applications: June 15, 2022)
• Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) (Closing Date for Applications: June 15, 2022)
• Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) (Closing Date for Applications: June 15, 2022)
• Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional) (Expiration Date: February 19, 2022)
• Notice of Special Interest (NOSI) in Research on Risk and Prevention of Black Youth Suicide (Expiration Date: July 31, 2022)
• Research Grants to Evaluate the Effectiveness of Physical Therapy-based Exercises and Movements Used to Reduce Older Adult Falls (U01). (Application Due Date: March 31, 2022)
• AHRQ Health Services Research Demonstration and Dissemination Grants (R18) (Expiration Date: September 30, 2022)
• AHRQ Small Research Grant Program (R03) (Expiration Date: July 07, 2022)
• AHRQ Health Services Research Projects (R01) (Expiration Date: July 07, 2022)
• Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) (Expiration Date: August 11, 2022)
• Occupational Safety and Health Research (R01) (Expiration Date: November 17, 2023)
• Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) (Expiration Date: February 06, 2023)
• Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional) (Expiration Date: February 17, 2023)
• Rural Emergency Medical Services Training Grant (Application Due Date: February 14, 2022)
• Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 – Clinical Trial Optional) (Expiration Date: May 08, 2024)
• Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) (Application Due Dates: February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
• Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (Application Due Dates: February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
• State Occupational Safety and Health Surveillance Program (U60) (Expiration Date: September 15, 2022)
• NIOSH Exploratory/Developmental Grant Program (R21) (Expiration Date: November 18, 2023)
• NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) (Expiration Date: November 16, 2023)
• Notice of Special Interest (NOSI): Research on Co-morbid Substance Use, Substance Use Disorders, and Other Psychiatric Disorders
• Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) (Expiration Date: August 11, 2022)
• Substance Use/Substance Use Disorder Dissertation Research Award (R36 – Clinical Trials Optional) (Expiration Date: May 08, 2023)
• Advancing Research on SUD through Computational Neuroscience 
• Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults
• Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (Expiration Date: September 08, 2023)
• Innovation at Work (Application due date: February 2022)
• Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) (Expiration Date: November 8, 2022)